Virological and immunological monitoring of the four groups of solid-organ transplant recipients with or without HCMV infection reactivation.

NA, not applicable.1Follow-up.2Patients of this group showed HCMV specific CD8+ only, until about 3 months after transplantation, then developed HCMV-specific CD4+ T-cells.3In some cases, clinicians preferred initiating antiviral therapy after reaching 100,000 (instead of 300,000) DNA copies/ml blood due to presence of end-organ disease.Virological and immunological monitoring of the four groups of solid-organ transplant recipients with or without HCMV infection reactivation.